Genmab Announces Data to be Presented at 2018 ASCO Annual Meeting

    NEXT STORY
    Immunomedics Announces Oral Presentation of Sacituzumab Govitecan in Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (mBC) at 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
    PREV STORY
    Teladoc Announces U.S. Launch of Behavioral Health Navigator
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Ascendis Pharma A/S Announces First Presentation of Preclinical Data Utilizing TransCon™ Technology in Oncology at SITC 2019

    author_avatar
    NASDAQ Market News

    R1 RCM Reports First Quarter 2019 Results

    author_avatar
    NASDAQ Market News

    Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea

    Helsinn and CJ Healthcare announce the approval of AKYNZEO® oral formulation in Korea CINV ...

    author_avatar
    NASDAQ Market News